West Pharmaceutical Services

Yahoo Finance • 29 days ago

Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)?

In early March 2026, West Pharmaceutical Services announced that long-time President, CEO and Board Chair Eric M. Green plans to retire in the second half of 2026, reaffirmed its February 12, 2026 guidance, and later received a shareholder... Full story

Yahoo Finance • last month

3 Reasons to Sell WST and 1 Stock to Buy Instead

West Pharmaceutical Services has been treading water for the past six months, recording a small loss of 2.7% while holding steady at $248.28. The stock also fell short of the S&P 500’s 3.1% gain during that period. Is there a buying oppor... Full story

Yahoo Finance • last month

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health – Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infring... Full story

Yahoo Finance • last month

Thursday Sector Laggards: Healthcare, Industrial

Looking at the sectors faring worst as of midday Thursday, shares of Healthcare companies are underperforming other sectors, showing a 0.1% loss. Within that group, West Pharmaceutical Services, Inc. (Symbol: WST) and Zoetis Inc (Symbol:... Full story

Yahoo Finance • last month

1 S&P 500 Stock on Our Watchlist and 2 We Find Risky

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitor... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story

Yahoo Finance • last month

Becton, Dickinson and Company (BDX): A Bull Case Theory

We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was trading at $176.66 as of February 26th. BDX’s t... Full story

Yahoo Finance • last month

UFP Technologies, Inc. (UFPT): A Bull Case Theory

We came across a bullish thesis on UFP Technologies, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on UFPT. UFP Technologies, Inc.'s share was trading at $215.67 as of February 26th. UFPT’s trailing P/E... Full story

Yahoo Finance • 2 months ago

BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure

West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 13 Best Strong Buy Dividend Stocks to Invest in.BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure On February 13, BofA lowered its pri... Full story

Yahoo Finance • 2 months ago

West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap Strategy returned -5.75% net of fees com... Full story

Yahoo Finance • 2 months ago

West Pharmaceutical announces up to $1B share repurchase program

[Stock Buyback Share Repurchase Word Collage 3d Illustration] iQoncept * West Pharmaceutical Services (WST [https://seekingalpha.com/symbol/WST]) said its board has authorized [https://seekingalpha.com/pr/20402532-west-announces-quarter... Full story

Yahoo Finance • 2 months ago

West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook

In the past week, West Pharmaceutical Services reported its 2025 results, with full-year sales rising to US$3.07 billion and net income edging up to US$493.7 million, while also issuing 2026 guidance that calls for first-quarter net sales... Full story

Yahoo Finance • 2 months ago

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Feb 12 (Reuters) - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on ‌strong demand for its proprietary products, which include syringes ‌and cartridges for inj... Full story

Yahoo Finance • 2 months ago

West Pharmaceutical: Q4 Earnings Snapshot

EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported fourth-quarter profit of $132.1 million. On a per-share basis, the Exton, Pennsylvania-based company said it had net income of $1.82. Earning... Full story

Yahoo Finance • 2 months ago

West Reports Fourth-Quarter and Full-Year 2025 Results

– Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON, Pa., Feb. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading prov... Full story

Yahoo Finance • 2 months ago

Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM

As the fourth-quarter earnings season unfolds, the ongoing week represents a key reporting window for several medical-sector companies. According to the latest Earnings Preview report, the Medical sector’s earnings likely faced pressure f... Full story

Yahoo Finance • 2 months ago

West Pharmaceutical Services, Inc. (WST): A Bull Case Theory

We came across a bullish thesis on West Pharmaceutical Services, Inc. on TipRanks™’s YouTube Channel. In this article, we will summarize the bulls’ thesis on WST. West Pharmaceutical Services, Inc.'s share was trading at $271.83 as of Janu... Full story

Yahoo Finance • 4 months ago

Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Nasdaq (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) ending the week in the red as the AI trade came under... Full story

Yahoo Finance • 4 months ago

West to Participate in Upcoming Investor Conference

EXTON, Pa., Dec. 12, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the J.P. Morgan Healthcare Confer... Full story

Yahoo Finance • 4 months ago

Most Stocks Recover from Oracle Sell-Off

The S&P 500 Index ($SPX) (SPY) on Thursday closed up by +0.21%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +1.34%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.35%.  December E-mini S&P futures (ESZ25) rose +0.2... Full story